, and APP are known to be a cause of familial forms of Alzheimer's disease (AD). APOE gene polymorphism is a strong risk genetic factor for AD. We have evaluated allele and genotype frequency distribution of rs11136000 polymorphism in the clusterin (CLU) gene (or apo lipoprotein J, APOJ) in the samples from three Russian populations and in AD patients. Genome wide asso ciation studies in samples from several European populations have recently revealed the highly significant association of CLU gene with AD (p = 8.5 × 10 -10 ). We found no differences in allele and genotype frequencies of rs11136000 between the populations from the Moscow, Ural, and Siberia regions. The allele frequencies are close to those in European populations. The genetic association analysis in cohort of AD patients and nor mal individuals (>500 individuals in each group) revealed no significant association of the rs11136000 poly morphism in CLU gene with Alzheimer's disease in Russian populations. Although our results showed that the CLU gene polymorphism rs11136000 is likely not a major genetic factor for the common form of Alzhe imer's disease, the data do not rule out the possibility of a modest effect of CLU and interaction between CLU and APOE genotypes in etiology of Alzheimer's disease.
INTRODUCTION
Alzheimer's disease (AD) is a neurodegenerative disorder and the most common cause of dementia among elderly people (50-60% of all dementia cases). To date four genes involved in the etiology of AD have been identified. The mutations in the genes encoding presenilins (PS1 and PS2) and the amyloid precursor protein (APP) are the major causes of early onset familial AD [1, 2] , which occurs in less than 5% of all AD cases [3, 4] . It was also shown that ε4 allele of the Abbreviations: AD-Alzheimer's disease; APOE-apolipopro tein E; APOJ-apolipoprotein J; CLU-clusterin; GWASgenome wide association study.
APOE gene is associated with late onset AD [5, 6] . APOE ε4 allele has been confirmed to be a strong risk factor for early and late onset AD in many human pop ulations, including Russian populations [7] .
Senile dementia is a complex disorder with hetero geneous pathogenesis [8] . Although a variety of genetic data has been collected, the role of genetic fac tors in the etiology of AD forms which are unlinked to known AD genes are still poorly understood.
A considerable progress in revealing putative AD disease associated genes has been done using genome wide association study (GWAS) . In one of the largest GWAS performed recently a significant association was found between AD and rs11136000 polymorphism in the intron of the CLU gene (or apolipoprotein J, APOJ) located on the chromosome 8. The associa tion was shown in two independent studies [9, 10] . As the genetic association should be confirmed in differ ent case control population samples we assessed the alleles and genotype frequencies of the CLU polymor phism in AD patients and cohort of healthy individuals from different Russian regions. [11] , DSM IV [12] and NINCDS/ADRDA [13] . In addition a cohort of dementia patients from Psychiatric Hospital no. 1 (Ufa) was involved.
MATERIAL AND METHODS
All patients were divided into two cohorts: (1) the early onset AD (214 individuals, age of onset <65 years, mean age of onset 56.9 ± 5.38) and (2) the late onset AD (320 individuals, age of onset 65 years and older, mean age of onset 72.2 ± 5.04). The genetic study was approved by the Ethics Committee with col lection of signed informed consents from participants or caregivers.
Genotyping
Genomic DNA was isolated from peripheral venous blood by the standard phenol chloroform extraction methodology [14] or using Qiagen kit for DNA isolation. Genotyping was performed by PCR followed by RFLP analysis. Amplification was per formed according to the manufacturer's instructions using Tercyc DNA amplifier (DNA technology, Rus sia) and GeneAmp PCR System 9700 Thermal Cycler (Applied Biosystems).
To genotype APOE gene locus, the following oligonu cleotide primers were used: 5' CGGCTGGGCGCG GACATGGAGGA and 5' TCGCGGGCCCCGGC CTGGTACAC. The PCR protocol was as follows: pre liminary denaturation at 95°C for 4 min; 5 cycles: 95°C for 45 s, 54°C for 25 s, and 72°C for 30 s; and 30 cycles: 95°C for 5 s, 58°C for 15 s, and 72°C for 5 s; the last stage was performed at 72°C for 3 min. PCR products were then cleaved by HhaI or BstHHI (SibEnzyme, Russia) and restriction products were analyzed in 7.5% polyacry lamide gel. The rs11136000 polymorphism in CLU gene was tested with the following oligonucleotide primers: 5' CTTTGTAATGATGTACCATCTACCC and 5' AGGCTGCAGACTCCCTGAAT. The PCR protocol was as follows: preliminary denaturation at 95°C for 1 min and 35 cycles: 94°C for 30 s, 57°C for 30 s, and 72°C for 1 min. The last stage was performed at 72°C. The 645 bp PCR products were then cleaved by AcsI restriction endonuclease (SibEnzyme, Russia) and restriction fragments were analyzed in 2% agarose gel (figure).
Statistics
A chi square test and Fisher's exact test were used to test differences between allele and genotype frequencies using the software available at http://ihg2.helmholtz_muenchen.de/cgi_bin/hw/ hwa1.pl.
RESULTS AND DISCUSSION
We have estimated the CLU gene rs11136000 poly morphism genotype and allele frequencies in popula tion samples from three regions of Russia: Moscow, Ural, and Siberia (Table 1 ). The general cohort was also divided into groups based on age and gender. Taking into account that products of both CLU and APOE genes may play major roles in transport and regulation of cerebral Aβ levels in brain [15, 16] all samples were also divided by the presence or absence of APOE ε4 allele.
We have shown that the frequencies of minor allele T of rs11136000 polymorphism (0.38-0.39) were the 
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same in different Russian population groups. Similar results were observed in the recent GWAS analyses in cohort of France, Belgium, Finland, Italy, and Spain populations (from 0.37 to 0.41 in different popula tions) [10] . Genotype frequencies showed no devia tion from Hardy Weinberg equilibrium in Moscow and Ural regions samples. No differences were found in the frequencies of the T allele in age and gender stratified groups as well as in groups of APOE ε4 carri ers or APOE ε4 non carriers (p > 0.05).
In the groups of very elderly individuals (89 years and older) and elderly individuals (from 65 years and older) from the Siberian region, the distribution of genotype frequencies was not in Hardy Weinberg equilibrium. The T allele frequency in these two groups was higher than in the group of individuals younger than 65 years (0.39). The TT genotype appears in the elder groups in a higher frequency (0.26) than in the group of individuals younger than 65 years (0.14). The statistically significant prevalence of TT genotype was found in the elderly groups versus the group of people younger than 65 years (p = 0.01793, OR = 0.354, CI = 0.147-0.852 for group of individuals from 65 years and older; p = 0.02086, OR = 0.340, CI = 0.133-0.869 for very elderly individ uals). Such deviations may occur due to a small sample number in groups of elderly individuals from Siberian population (50 persons). However, the possibility that T allele of the CLU gene indeed occurs in higher fre quency in elderly population cannot be excluded.
The prevalence of T allele (p = 0.01027) or TT geno type (0.01079) were also found in a cohort of healthy APOE ε4 carriers. Similarly, in population of Moscow the T allele was more frequent in APOE ε4 allele carri ers (0.45) versus non carriers (0.38), though these dif ferences were not significant (p = 0.098).
Pairwise comparison of CLU polymorphism alleles and genotypes frequencies in three Russian regions (Moscow, Ural, and Siberian) did not reveal any statis tically significant differences (p > 0.05 for all pairs). This result allowed us to combine all 3 population groups into one large control group. AD patients col lection consisted of cases collected in Moscow and Ural regions. The distributions of rs11136000 poly morphism genotypes and alleles frequencies among cases and healthy individuals are shown in Table 2 .
The frequency of T allele rs11136000 polymor phism in Russian cases group (0.38-0.39) was similar to described previously for European populations (0.35). Although in the groups with early and late onset AD T allele frequency was lower than in the con trol group (0.38), we found no statistically significant differences between these groups. The TT genotype in total AD patients group was more rare than in control group of the same age. The most significant difference in TT genotype frequency was seen in patients with late onset AD and elderly control group (p = 0.04929, OR = 0.612).
Genetic associations depend on many uncontrol lable factors such as assortativity and genetic heteroge neity of the case control groups. Our study of Siberian population revealed differences in allele and geno type frequencies between longevity group and other cohorts. We observed no statistically significant dif ferences in allele and genotype frequencies between groups of late onset AD patients and healthy individ uals if very elderly Siberians are excluded from the analysis. Taking into account the possible interaction between CLU and APOE gene products as well as dif ferences in T allele and TT genotype frequencies observed in population groups stratified by APOE sta tus, we analyzed the CLU gene SNP in both groups of APOE ε4 carriers and non carriers (Table 3) . We found statistically significant association of rs11136000 poly morphism with AD (p = 0.03255 for T allele and p = 0.03475 for TT genotype) in APOE ε4 carrier group but not in APOE ε4 non carriers.
Until now, the role of CLU gene product in AD eti ology is unclear. There is an evidence that in individu als with AD, CLU gene expression is increased in affected cortical areas of brain [17] . The protein product of this gene as well as of APOE was found in amyloid plaques and in the cerebrospinal fluid [18] . It is assumed that CLU and APOE proteins can reg ulate extracellular level of Aβ by transferring it through hematoencephalic barrier in opposite directions [15, 16] .
Although our results have not proved the rs11136000 polymorphism in CLU gene to be a strong risk factor for common AD they do not exclude its probable role as a moderate risk factor for the late onset AD. Our preliminary data show that different interactions between CLU and APOE genotypes could play diverse roles in the AD etiology. It should be noted that in European populations association of rs11136000 with AD was more significant in APOE ε4 carriers than in non carriers. The differences in CLU allele frequencies between cases and controls in APOE ε4 carriers from Russian populations also suggested a combined role of APOE and CLU gene polymorphism in pathogenesis of AD. The difference in frequency of rs11136000 alleles and genotypes between groups of individuals younger and older than 65 years suggests that CLU gene may affect life span.
Further studies of larger population groups strati fied by age and of different ethnic origin can clarify the possible interactions between CLU and APOE genes and aging in the etiology of AD. 
